Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Urological research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00296871PMID 7740652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate

  2005cited by this paper
• Peptides and growth factors in small cell lung cancer: production, binding sites, and growth effects

  2004cited by this paper
• Calcitonin immunoreactive cells in prostate gland and cloacal derived tissues

  2004cited by this paper
• The endocrine cells of the digestive system: amines, peptides, and modes of action

  2004cited by this paper
• Human chromogranin A gene. Molecular cloning, structural analysis, and neuroendocrine cell-specific expression.

  1994cited by this paper
• Tumors of the endocrine/neuroendocrine system: an overview.

  1994cited by this paper
• Neuroendocrine differentiation in metastatic prostatic adenocarcinoma.

  1994cited by this paper
• Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases.

  1994cited by this paper
• Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.

  1994cited by this paper
• Parathyroid hormone-related protein is expressed by prostatic neuroendocrine cells.

  1994cited by this paper
• Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic and neoplastic prostate

  1994cited by this paper
• Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients.

  1994cited by this paper
• Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers.

  1994cited by this paper
• Mortality trend from prostate cancer in the Netherlands (1950‐1989)

  1994cited by this paper
• Calcitonin releases acid phosphatase from rat ventral prostate explants.

  1994cited by this paper
• Neuroendocrine differentiation in prostatic adenocarcinoma does not represent true Paneth cell differentiation.

  1994cited by this paper
• Paracrine effects of bombesin/gastrin‐releasing peptide and other growth factors on pulmonary neuroendocrine cells in vitro

  1993cited by this paper
• Neuroendocrine cells in the human prostate gland.

  1993cited by this paper
• Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia.

  1993cited by this paper
• The androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue.

  1993cited by this paper
• Effect of somatostatin analog RC‐160 and bombesin/gastrin releasing peptide antagonist RC‐3095 on growth of PC‐3 human prostate‐cancer xenografts in nude mice

  1993influential reference
• Antagonists of bombesin/gastrin‐releasing peptide as adjuncts to agonists of luteinizing hormone–releasing hormone in the treatment of experimental prostate cancer

  1993cited by this paper
• Treatment of brain metastases from bladder cancer.

  1993cited by this paper
• Do neuroendocrine cells in human prostate cancer express androgen receptor?

  1993influential reference
• Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice.

  1993cited by this paper
• The neuroendocrine cell population of the human prostate gland.

  1993cited by this paper
• Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: possible mechanism of action.

  1993cited by this paper
• Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma

  1993influential reference
• Calcitonin inhibits the growth of human gastric carcinoma cell line KATO III.

  1992influential reference
• Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications

  1992cited by this paper
• Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications.

  1992cited by this paper
• Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients.

  1992cited by this paper
• Inhibition of growth of PC‐82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC‐3095 or combination of agonist [D‐Trp6]‐luteinizing hormone‐releasing hormone and somatostatin analog RC‐160

  1992cited by this paper
• The chromogranins A and B: The first 25 years and future perspectives

  1992influential reference
• Neuroendocrine differentiation in human prostatic carcinoma

  1992cited by this paper
• Presence of calcitonin‐like immunoreactivity (iCT) in human prostate gland: Evidence for iCT secretion by cultured prostate cells

  1992cited by this paper
• Neuroendocrine differentiation in human prostatic carcinoma.

  1992cited by this paper
• Relation of endocrine‐paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate

  1991cited by this paper
• Investigation on serum neurone‐specific enolase in prostate cancer diagnosis and monitoring: Comparative study of a multiple tumor marker assay

  1991cited by this paper
• [Psi13,14] Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo

  1991cited by this paper
• [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.

  1991cited by this paper
• Neuro-endocrine cells--a new prognostic parameter in prostate cancer.

  1991cited by this paper
• Dopaminergic and ligand-independent activation of steroid hormone receptors.

  1991cited by this paper
• National Cancer Institute roundtable on prostate cancer: future research directions.

  1991cited by this paper
• Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.

  1991cited by this paper
• Elevated plasma chromogranin-A concentrations in prostatic carcinoma.

  1991cited by this paper
• Androgen receptors in endocrine‐therapy‐resistant human prostate cancer

  1991cited by this paper
• Production of calcitonin gene related peptide, calcitonin and PTH‐related protein by a prostatic adenocarcinoma

  1991cited by this paper
• Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration.

  1990cited by this paper
• Evaluation of receptors for somatostatin in various tumors using different analogs.

  1990cited by this paper
• Serotonin as a growth factor.

  1990cited by this paper
• Prostatic carcinoma: histological and immunohistological factors affecting prognosis.

  1990cited by this paper
• Bombesin stimulates growth of human prostatic cancer cells in vitro

  1990cited by this paper
• The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker".

  1989cited by this paper
• Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells.

  1989cited by this paper
• Isolation of a human seminal plasma peptide with bombesin-like activity.

  1989cited by this paper
• Site‐specific growth of the prostate xenograft line UCRU‐PR‐2

  1989cited by this paper
• Immunoreactive somatostatin in male reproductive system in humans.

  1989cited by this paper
• Neuropeptides as growth factors. Possible roles in human diseases.

  1989cited by this paper
• Calcitonin, katacalcin, and calcitonin gene-related peptide in the human prostate. An immunocytochemical and immunoelectron microscopic study.

  1989cited by this paper
• Partial characterization of a thyroid‐stimulating hormone‐like peptide in neuroendocrine cells of the human prostate gland

  1989cited by this paper
• The neuroendocrine prostate: characterization and quantitation of calcitonin in the human gland.

  1989cited by this paper
• Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer.

  1989cited by this paper
• Xenografted small cell undifferentiated cancer of prostate: Possible common origin with prostatic adenocarcinoma

  1988cited by this paper
• Serotonin stimulates DNA synthesis in fibroblasts acting through 5–HT1B receptors coupled to a Gi-protein

  1988cited by this paper
• Clonal origin of columnar, mucous, and endocrine cell lineages in human colorectal epithelium

  1988cited by this paper
• Ectopic hormone production by a prostatic small cell carcinoma xenograft line.

  1988cited by this paper
• Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.

  1988influential reference
• Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease.

  1988cited by this paper
• Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D‐Trp‐6‐LH‐RH

  1988cited by this paper
• Partial inhibition of the growth of transplanted dunning rat prostate tumors with the long-acting somatostatin analogue sandostatin (SMS 201-995).

  1988cited by this paper
• Neuroendocrine differentiation and prostatic carcinoma. The concept 'comes of age'.

  1988cited by this paper
• Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway.

  1988cited by this paper
• Neuroendocrine differentiation and prostatic carcinoma. The concept 'comes of age'.

  1988cited by this paper
• Somatostatin receptors in human endocrine tumors.

  1987cited by this paper
• Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin.

  1987cited by this paper
• Glycoprotein hormone alpha-chain-immunoreactive endocrine cells in prostate and cloacal-derived tissues.

  1987cited by this paper
• Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.

  1987cited by this paper
• Paraneoplastic syndromes associated with prostatic carcinoma.

  1987cited by this paper
• Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate.

  1987influential reference
• Small cell carcinoma of the prostate part I a clinicopathologic study of 20 cases

  1987influential reference
• Age-related changes in the neuroendocrine (endocrine-paracrine) cell population and the serotonin content of the guinea pig prostate.

  1987cited by this paper
• A.P.U.D. type endocrine tumour of the prostate. Incidence and prognosis in association with adenocarcinoma.

  1987cited by this paper
• Calcitonin induces ornithine decarboxylase in various rat tissues.

  1987cited by this paper
• Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases

  1987cited by this paper
• Biogenic amines as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells (review).

  1987cited by this paper
• Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands.

  1986cited by this paper
• Chromogranin A, B, and C in human adrenal medulla and endocrine tissues.

  1986cited by this paper
• Calcitoninlike immunoreactive and bombesinlike immunoreactive endocrine-paracrine cells of the human prostate.

  1986cited by this paper
• Calcitoninlike immunoreactive and bombesinlike immunoreactive endocrine-paracrine cells of the human prostate.

  1986cited by this paper
• Argyrophilic, 'carcinoid-like' prostatic carcinoma. An immunocytochemical study.

  1986cited by this paper
• Prostatic adenocarcinoma evolving into carcinoid: selective effect of hormonal treatment?

  1986influential reference
• Calcitonin stimulation of cyclic adenosine 3':5'-monophosphate production with growth inhibition in human renal adenocarcinoma cell lines.

  1985cited by this paper
• Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues.

  1985cited by this paper
• Human prostatic endocrine-paracrine (APUD) cells. Distributional analysis with a comparison of serotonin and neuron-specific enolase immunoreactivity and silver stains.

  1985cited by this paper
• Endocrine-paracrine cells in prostatic carcinoma and clinical course of the disease.

  1985cited by this paper
• Human prostatic endocrine-paracrine (APUD) cells. Distributional analysis with a comparison of serotonin and neuron-specific enolase immunoreactivity and silver stains.

  1985cited by this paper
• Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

  1985cited by this paper
• The histogenesis of small cell carcinoma of the prostate an immunohistochemical study

  1984cited by this paper
• Endocrine-paracrine cells of the prostate and prostatic urethra: An ultrastructural study*

  1984cited by this paper

• xCT as a potential marker for neuroendocrine cells in high-risk prostate cancer and the relation to AL122023.1-miR-26a/30d/30e axis

  2025cites this paper
• Cells of Origin for Prostate Cancer.

  2019cites this paper
• Investigating the role of the secreted tumour suppressor Dickkopf-3 in stromal-epithelial interactions in prostate cancer

  2017cites this paper
• Regulation of the glucocorticoid receptor in prostate cancer disease progression and resistance to anti-androgen therapy

  2017cites this paper
• Mono-ubiquitination mediated regulation of KMT5A and its role in prostate cancer

  2017cites this paper
• The role of inhibitor of apoptosis (IAP) family member survivin in prostatic disease

  2017cites this paper
• The in vitro differentiation of prostate epithelial cells and gonadal adipocytes from mouse embryonic stem cells

  2017cites this paper
• Docetaxel resistance in castration resistant prostate cancer: the role of c-Jun and the androgen receptor

  2015cites this paper
• Identification of the Polycomb protein CBX2 as a potential drug target in advanced prostate cancer and beyond

  2015cites this paper
• Alteration of Loperamide-Induced Prostate Relaxation in High-Fat Diet-Fed Rats

  2014cites this paper
• Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression

  2014cites this paper
• Opium Consumption Is Negatively Associated With Serum Prostate-Specific Antigen (PSA), Free PSA, and Percentage of Free PSA Levels

  2013cites this paper
• Individual Rac GTPases Mediate Aspects of Prostate Cancer Cell and Bone Marrow Endothelial Cell Interactions

  2011cites this paper
• Localization, density and shape of serotonin - and chromogranin a-positive neuroendocrine cells in feline bulbourethral glands.

  2011cites this paper
• Minority Undergraduate Research in Prostate Cancer: Bridging Opportunities for Postbaccalaureate Education

  2010cites this paper
• Cancer stem cells - A therapeutic target?

  2010cites this paper
• GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches.

  2009cites this paper
• Correlation of neuroendocrine differentiation and PTEN expression with pathologic effects after bicalutamide monotherapy in prostate cancer

  2009cites this paper
• Robust expression of Prominin-2 all along the adult male reproductive system and urinary bladder

  2008cites this paper
• The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

  2008cites this paper
• Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer.

  2007cites this paper
• Neuroendocrine cells and peptidergic innervation in human and rat prostate.

  2007cites this paper
• Effect of Prolactin and Bromocriptine on the Population of Prostate Neuroendocrine Cells from Intact and Cyproterone Acetate‐Treated Rats: Stereological and Immunohistochemical Study

  2007cites this paper
• Physiology of the Male Accessory Sex Structures: The Prostate Gland, Seminal Vesicles, and Bulbourethral Glands

  2006cites this paper
• Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies.

  2005cites this paper
• Characterization of prostatic neuroendocrine cell line established from neuroendocrine carcinoma of transgenic mouse allograft model

  2005cites this paper
• Opioid peptides in cancer

  2004cites this paper
• NE-10 Neuroendocrine Cancer Promotes the LNCaP Xenograft Growth in Castrated Mice

  2004cites this paper
• Effects of combined androgen blockade on bone metabolism and density in men with locally advanced prostate cancer

  2004cites this paper
• Ultrastructural and immunocytochemical analyses of opioid treatment effects on PC3 prostatic cancer cells

  2004cites this paper
• The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line.

  2004cites this paper
• Rôle de la protéine tyrosine kinase Fer dans le cancer de la prostate

  2004cites this paper
• Characterizationof ProstaticNeuroendocrine Cell Line Established FromNeuroendocrine

  2004cites this paper
• Immunohistochemical detection of gastrin releasing peptide in patients with prostate cancer

  2003cites this paper
• Naturally Occurring Oligopeptides with More than One Biological Activities

  2003cites this paper
• Different profiles of neuroendocrine cell differentiation evolve in the PC‐310 human prostate cancer model during long‐term androgen deprivation

  2002cites this paper
• Stereologic Estimation of the Number of Neuroendocrine Cells in Normal Human Prostate Detected by Immunohistochemistry

  2002cites this paper
• Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines.

  2002cites this paper
• Precancerous Lesions and Conditions of the Prostate

  2002cites this paper
• Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention.

  2002cites this paper
• Semiquantitative morphology of human prostatic development and regional distribution of prostatic neuroendocrine cells

  2001cites this paper
• Role of stimulatory guanine nucleotide binding protein (Gsα) in proliferation of PC‐3M prostate cancer cells

  2001cites this paper
• Immunohistochemical Localization of Protein Gene Product 9.5, Ubiquitin, and Neuropeptide Y Immunoreactivities in Epithelial and Neuroendocrine Cells from Normal and Hyperplastic Human Prostate

  2000cites this paper
• Androgen‐independent growth is induced by neuropeptides in human prostate cancer cell lines

  2000cites this paper
• Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.

  2000cites this paper
• Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance

  2000cites this paper
• Neuroendocrine cells during human prostate development: Does neuroendocrine cell density remain constant during fetal as well as postnatal life?

  2000cites this paper
• Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model.

  1999cites this paper
• Inhibition by vasoactive intestinal polypeptide (VIP) of angiogenesis induced by murine Colon 26-L5 carcinoma cells metastasized in liver

  1999cites this paper
• Neurogenic origin of human prostate endocrine cells.

  1999cites this paper
• Immunohistochemistry and in situ hybridization of the androgen receptor in the developing human prostate

  1998cites this paper
• Modulation of the estrogen‐regulated proteins cathepsin D and pS2 by opioid agonists in hormone‐sensitive breast cancer cell lines (MCF7 and T47D): Evidence for an interaction between the two systems

  1998cites this paper
• Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted medium.

  1997cites this paper
• Molecular and cellular biology of prostate cancer

  1997cites this paper
• Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment.

  1997cites this paper
• Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors.

  1997cites this paper
• Neuroendocrine differentiation in human prostatic tumor models.

  1996cites this paper
• Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancer.

  1995cites this paper
• The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long‐term follow‐up study with patients treated by radical prostatectomy

  1995cites this paper